Skip to content

A novel education-based intervention to reduce inappropriate antibiotic prescribing in the treatment of gonorrhea in China: protocol for a cluster randomized trial

A novel education-based intervention to reduce inappropriate antibiotic prescribing in the treatment of gonorrhea in China: protocol for a cluster randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029591
Enrollment
Unknown
Registered
2020-02-05
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gonorrhea

Interventions

control arm:none
intervention arm:on-line training on doctors

Sponsors

Institute of Dermatology, CAMS/National Center for STD Control, China CDC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Hospitals with the out-patient departments of dermatology (dermatovenerology), urology, or andrology; 2. Hospitals with the storage of ceftriaxone and/or spectinomycin.

Exclusion criteria

Exclusion criteria: 1. National or province-level hospitals; 2. Unwilling or unable to comply with all the requirements of the study.

Design outcomes

Primary

MeasureTime frame
the proportion of prescriptions adherent to the regimens for treatment of uncomplicated gonorrhea recommended by the National Guidelines;

Secondary

MeasureTime frame
factors related to prescribing behaviors nonadherent to the National Guidelines among doctors;

Countries

China

Contacts

Public ContactChen Xiangsheng

Institute of Dermatology, CAMS/National Center for STD Control, China CDC

chenxs@ncstdlc.org+86 13505162335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026